{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:05:45Z","timestamp":1781647545662,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jagp.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T05:46:15Z","timestamp":1386222375000},"page":"373-383","source":"Crossref","is-referenced-by-count":34,"title":["Memantine for Lewy Body Disorders: Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Shinji","family":"Matsunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2013.11.007_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000201565","article-title":"Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century","volume":"32","author":"Yamawaki","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jagp.2013.11.007_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jagp.2012.12.007","article-title":"Prevalence of Parkinson disease and Parkinson disease dementia in community nursing homes","volume":"21","author":"Hoegh","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2013.11.007_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2013.11.007_bib4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jpsychires.2013.04.013","article-title":"NMDA receptor antagonists interventions in schizophrenia: meta-analysis of randomized, placebo-controlled trials","volume":"47","author":"Kishi","year":"2013","journal-title":"J\u00a0Psych Res"},{"key":"10.1016\/j.jagp.2013.11.007_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JGP.0b013e31822001a6","article-title":"Pharmacologic treatment of apathy in dementia","volume":"20","author":"Berman","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2013.11.007_bib6","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/gps.938","article-title":"The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence","volume":"18","author":"Danysz","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2013.11.007_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","article-title":"Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein\/phospholipase C (PLCbeta1) interactions","volume":"14","author":"Dalfo","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jagp.2013.11.007_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/syn.890190405","article-title":"Glutamate\/dopamine D1\/D2 balance in the basal ganglia and its relevance to Parkinson's disease","volume":"19","author":"Starr","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.jagp.2013.11.007_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF02682089","article-title":"Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats","volume":"130","author":"Kucheryanu","year":"2000","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.jagp.2013.11.007_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2013.11.007_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2013.11.007_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.22495","article-title":"Randomized controlled trial of memantine in dementia associated with Parkinson's disease","volume":"24","author":"Leroi","year":"2009","journal-title":"Move Dis"},{"key":"10.1016\/j.jagp.2013.11.007_bib13","first-page":"301","article-title":"Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease [In Chinese]","volume":"91","author":"Li","year":"2011","journal-title":"Zhonghua yi xue za zhi"},{"key":"10.1016\/j.jagp.2013.11.007_bib14","first-page":"273","article-title":"Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study","volume":"22","author":"Merello","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jagp.2013.11.007_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.parkreldis.2010.12.003","article-title":"Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial","volume":"17","author":"Ondo","year":"2011","journal-title":"Parkinson Relat Dis"},{"key":"10.1016\/j.jagp.2013.11.007_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp-2012-303182","article-title":"Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study","volume":"84","author":"Moreau","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.jagp.2013.11.007_bib17","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheim Dis Assoc Dis"},{"key":"10.1016\/j.jagp.2013.11.007_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/089198879600900404","article-title":"Clinical evaluation of global change in Alzheimer's disease: identifying consensus","volume":"9","author":"Olin","year":"1996","journal-title":"J\u00a0Geriatr Psych Neurol"},{"key":"10.1016\/j.jagp.2013.11.007_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psych Res"},{"key":"10.1016\/j.jagp.2013.11.007_bib20","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2013.11.007_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5014\/ajot.53.5.471","article-title":"Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia","volume":"53","author":"Gelinas","year":"1999","journal-title":"Am J Occup Ther"},{"issue":"suppl 2","key":"10.1016\/j.jagp.2013.11.007_bib22","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheim Dis Assoc Dis"},{"key":"10.1016\/j.jagp.2013.11.007_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/1082-989X.8.3.243","article-title":"How meta-analysis increases statistical power","volume":"8","author":"Cohn","year":"2003","journal-title":"Psychol Methods"},{"key":"10.1016\/j.jagp.2013.11.007_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jagp.2013.11.007_bib25","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2013.11.007_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.10248","article-title":"Systematic evaluation of rating scales for impairment and disability in Parkinson's disease","volume":"17","author":"Ramaker","year":"2002","journal-title":"Move Dis"},{"key":"10.1016\/j.jagp.2013.11.007_bib27","unstructured":"Fahn S, Elton R, Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ, Macmillan Healthcare Information, 1987, pp 153\u2013164"},{"key":"10.1016\/j.jagp.2013.11.007_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0404.1997.tb00299.x","article-title":"The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies","volume":"96","author":"Ballard","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jagp.2013.11.007_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2013.11.007_bib30","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jagp.2013.11.007_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jagp.2013.02.020","article-title":"Neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies: what geriatric psychiatry can learn","volume":"21","author":"Weintraub","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2013.11.007_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","article-title":"Amyloid PET imaging in Lewy body disorders","volume":"23","author":"Donaghy","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2013.11.007_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000345989","article-title":"Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine","volume":"35","author":"Boada","year":"2013","journal-title":"Dement Geriatr Cogn Dis"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474811300420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474811300420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T14:22:49Z","timestamp":1539008569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106474811300420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S106474811300420X"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2013.11.007","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}